ReviewCancers2026

Targeting Mesenchymal-Epidermal Transition (MET) Aberrations in Non-Small Cell Lung Cancer: Current Challenges and Therapeutic Advances.

Fahua Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.